Literature DB >> 25109357

Continuous hypoxia regulates the osteogenic potential of mesenchymal stem cells in a time-dependent manner.

Hao Ding1, Song Chen1, Jun-Hui Yin1, Xue-Tao Xie1, Zhen-Hong Zhu1, You-Shui Gao1, Chang-Qing Zhang1.   

Abstract

The effects of hypoxia on the osteogenic potential of mesenchymal stem cells (MSCs) have been previously reported. From these studies, possible factors affecting the association between hypoxia and the osteogenic differentiation of MSCs have been suggested, including hypoxia severity, cell origin and methods of induction. The effect of the duration of hypoxia, however, remains poorly understood. The aim of the present study was to investigate the effect of continuous hypoxia on the induced osteogenesis of MSCs. Rat MSCs were isolated and cultured in vitro. Once the cells had been cultured to passage three, they were switched to 1% oxygen and cultured either with or without osteogenic medium, while cells in the control groups were cultured under normoxia in corresponding conditions. Four osteogenic differentiation biomarkers, runt-related transcription factor 2, osteopontin, osteocalcin and alkaline phosphatase, were analyzed by quantitative polymerase chain reaction and western blotting at defined intervals throughout the culture period. In addition, Alizarin Red staining was used to assess changes in mineralization. The results showed that 1% hypoxia was able to enhance and accelerate the osteogenic ability of the MSCs during the initial phases of differentiation, and the protein expression of certain associated biomarkers was upregulated. However, continuous hypoxia was shown to impair osteogenesis in the latter stages of differentiation. These findings suggest that hypoxia can regulate the osteogenesis of MSCs in a time-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25109357     DOI: 10.3892/mmr.2014.2451

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

Review 1.  Towards Three-Dimensional Dynamic Regulation and In Situ Characterization of Single Stem Cell Phenotype Using Microfluidics.

Authors:  Sébastien Sart; Spiros N Agathos
Journal:  Mol Biotechnol       Date:  2018-11       Impact factor: 2.695

2.  Cell therapy for osteonecrosis of femoral head and joint preservation.

Authors:  You Seung Chun; Dong Hwan Lee; Tae Gu Won; Chan Sik Kim; Asode Ananthram Shetty; Seok Jung Kim
Journal:  J Clin Orthop Trauma       Date:  2021-11-27

3.  Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head.

Authors:  Zhen-Hong Zhu; Wen-Qi Song; Chang-Qing Zhang; Ji-Min Yin
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

4.  Piezo type mechanosensitive ion channel component 1 functions as a regulator of the cell fate determination of mesenchymal stem cells.

Authors:  Asuna Sugimoto; Aya Miyazaki; Keita Kawarabayashi; Masayuki Shono; Yuki Akazawa; Tomokazu Hasegawa; Kimiko Ueda-Yamaguchi; Takamasa Kitamura; Keigo Yoshizaki; Satoshi Fukumoto; Tsutomu Iwamoto
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

5.  Can Hypoxic Conditioning Improve Bone Metabolism? A Systematic Review.

Authors:  Marta Camacho-Cardenosa; Alba Camacho-Cardenosa; Rafael Timón; Guillermo Olcina; Pablo Tomas-Carus; Javier Brazo-Sayavera
Journal:  Int J Environ Res Public Health       Date:  2019-05-21       Impact factor: 3.390

6.  Zinc Inhibits HIF-Prolyl Hydroxylase Inhibitor-Aggravated VSMC Calcification Induced by High Phosphate.

Authors:  Annamária Nagy; Dávid Pethő; Tamás Gáll; Erzsébet Zavaczki; Mónika Nyitrai; József Posta; Abolfazl Zarjou; Anupam Agarwal; György Balla; József Balla
Journal:  Front Physiol       Date:  2020-01-15       Impact factor: 4.566

7.  Osteogenic Potential of Mesenchymal Stem Cells from Adipose Tissue, Bone Marrow and Hair Follicle Outer Root Sheath in a 3D Crosslinked Gelatin-Based Hydrogel.

Authors:  Hanluo Li; Hafiz Awais Nawaz; Federica Francesca Masieri; Sarah Vogel; Ute Hempel; Alexander K Bartella; Rüdiger Zimmerer; Jan-Christoph Simon; Michaela Schulz-Siegmund; Michael Hacker; Bernd Lethaus; Vuk Savković
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

8.  Crohn's disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients' disease stage and to bone mineral density.

Authors:  Martina Blaschke; Regine Koepp; Christof Lenz; Jochen Kruppa; Klaus Jung; Heide Siggelkow
Journal:  J Clin Transl Endocrinol       Date:  2018-06-19

9.  Nanosecond pulsed electric fields enhance mesenchymal stem cells differentiation via DNMT1-regulated OCT4/NANOG gene expression.

Authors:  Kejia Li; Tong Ning; Hao Wang; Yangzi Jiang; Jue Zhang; Zigang Ge
Journal:  Stem Cell Res Ther       Date:  2020-07-22       Impact factor: 6.832

Review 10.  Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research.

Authors:  Rui Li; Qiu-Xia Lin; Xue-Zhen Liang; Guang-Bo Liu; He Tang; Yu Wang; Shi-Bi Lu; Jiang Peng
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.